RxDoctor Payments Data

Azazuddin Ahmed, MD

Internal Medicine · Chicago, ILNPI 1073732459

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,130 of the $2,282 with a category attached, or 93.4%. Novo Nordisk accounts for 96.2% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $2,153, more than ten times the $27 reported in 2019.

$2,282in general payments, 2019–2025

Across 8 payments — averaging $285.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Amgen$27
  • Travere Therapeutics, Inc.$23
  • Lilly USA, LLC$21
  • Johnson & Johnson$16
$909,836in research payments, 2019–2025

Across 667 payments — averaging $1364.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk AS$348K
  • Kowa Research Institute, Inc.$329K
  • Sanofi US Services Inc.$83K
  • Sanofi-aventis U.S. LLC$80K
  • AstraZeneca$41K
  • Lexicon Pharmaceuticals, Inc.$28K

What the payments were for

  • Consulting fees$2,13093%
  • Food & beverage$874%
  • Education$653%

General payments by program year

19
20
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,282 in reported general payments places this provider in the 85th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$10,258
Medicare patients
37
Services billed
73

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →